Amneal Pharmaceuticals Shares Are Trading Higher After the Company Announced FDA Approval of OTC Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opiod Overdose
Amneal Pharmicals宣佈美國食品藥品管理局批准非處方鹽酸納洛酮鼻腔噴霧劑用於阿片類藥物過量的緊急治療後,該公司股價走高
Amneal Pharmaceuticals Shares Are Trading Higher After the Company Announced FDA Approval of OTC Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opiod Overdose
Amneal Pharmicals宣佈美國食品藥品管理局批准非處方鹽酸納洛酮鼻腔噴霧劑用於阿片類藥物過量的緊急治療後,該公司股價走高
使用瀏覽器的分享功能,分享給你的好友吧